USX:LMDXW - LumiraDx Ltd

LumiraDx Limited Warrant
Sector: Health Care, Industry: Life Sciences Tools & Services

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance Note: This stock seems to be inactive

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2019 Q4	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	-	-	0% -	-	0% -	0% -	0% -	0% -	0% -
Net Margin	[friend]	[friend]	[friend]	[friend]	-17.71% -	-44.15% -	-24.02% -	5.36% -	-27.19% -	-115.87% -	-176.59% -	-290.38% -	-267.19% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	17.04% -58.0%	34.52% 102.6%	35.96% 4.2%	35.89% -0.2%	37.2% 3.7%	35.59% -4.3%	-13.87% -	-57.97% -	-80.48% -
Operating Margin	[friend]	[friend]	[friend]	[friend]	-53.14% -	-28.98% -	-34.5% -	-35.24% -	-47.55% -	-57.88% -	-126.32% -	-225.24% -	-242.15% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	87.22M -18.4%	415.45M 376.3%	421.43M 1.4%	440.97M 4.6%	398.47M -9.6%	331.61M -16.8%	254.48M -23.3%	150.24M -41.0%	126.52M -15.8%
Total Assets	[friend]	[friend]	[friend]	[friend]	-	711.4M -	644.78M -9.4%	659.23M 2.2%	574.34M -12.9%	568.71M -1.0%	441.01M -22.5%	392.31M -11.0%	341.61M -12.9%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	-	526M -	482.18M -8.3%	534.37M 10.8%	558.84M 4.6%	550.89M -1.4%	546.39M -0.8%	545.91M -0.1%	555.55M 1.8%
Total Equity	[friend]	[friend]	[friend]	[friend]	-	184.86M -	163.05M -11.8%	125.23M -23.2%	15.81M -87.4%	18.08M 14.3%	-105.11M -	-153.43M -	-213.83M -
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	-48.63M -	-107.04M -	-134.88M -	-127.01M -	-161.12M -	-186.89M -	-162.11M -	-185.22M -	-129.71M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	334.52M 107.6%	37.55M -88.8%	161.17M 329.2%	334.52M 107.6%	246.46M -26.3%	217.73M -11.7%	132.15M -39.3%	166.05M 25.7%	106.45M -35.9%
End Cash Position	[friend]	[friend]	[friend]	[friend]	246.46M -26.3%	223.07M -9.5%	132.15M -40.8%	177.87M 34.6%	126.97M -28.6%	150.16M 18.3%	100.01M -33.4%	73.66M -26.4%	24.07M -67.3%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	-74.94M -	-217.14M -	-241.23M -	-208.19M -	-222.46M -	-234.42M -	-187.09M -	-201.68M -	-140.52M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	-15.17M -	-182.89M -	-100.76M -	23.86M -	-108.36M -	-384.2M -	-449.19M -	-436.06M -	-337.84M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	-15.45M -	-183.4M -	-101.21M -	23.65M -	-108.35M -	-384.25M -	-449.38M -	-436.26M -	-338.04M -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	-	-99.21% -	-21.3% -	18.89% -	-685.31% -	-378.69% -	-	-	-
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	-	-25.78% -	-5.46% -	3.59% -	-18.87% -	-60.03% -	-19.93% -	-82.98% -	-73.81% -